CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 5 enrolled
Drug / intervention
CDC infusionbiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03129568
NCT03129568Phase 1Completed
CompareCT.gov

A Prospective Phase 1 Trial of Cardiac Progenitor Cell Therapy in Children With Dilated Cardiomyopathy

Okayama University·interventional·Posted Apr 26, 2017·Updated Nov 26, 2021

In Brief

A Phase 1 clinical trial evaluating CDC infusion for Dilated Cardiomyopathy. Completed, enrolled 5 participants across 1 site.

Detailed Summary

A phase 1 prospective study to determine the procedural feasibility and safety and preliminary efficacy of intracoronary infusion of cardiosphere-derived cells (CDCs) in patients with dilated cardiomyopathy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDilated Cardiomyopathy
CountriesJapan
CollaboratorsTranslational Research Center for Medical Innovation, Kobe, Hyogo, Japan

Timeline

Phase 1CompletedFinished
201820192020202120222023202420252026
First PostedApr 26, 2017
Enrollment StartApr 14, 2017
Primary CompletionSep 17, 2018
Study CompletionDec 9, 2020
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 9.2 years ago

Interventions

CDC infusionbiological

Injection of CDCs (0.3 million per kg of body weight).